A closer look at the scalp: could trichoscopy predict fungal cure?
NCT ID NCT07043582
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This observational study in children and adolescents with tinea capitis (a scalp fungal infection) investigates whether changes seen under a trichoscope—a special microscope for hair and scalp—can predict when the infection is cured. Participants receive the antifungal drug terbinafine for 4 weeks and are monitored every 4 weeks with trichoscopy and lab tests. The goal is to see if certain trichoscopic signs, like black dots or corkscrew hairs, disappear at the same time as the fungus clears, and whether initial severity predicts longer treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- terbinafine
- What this could lead to
- If successful, this could help doctors predict treatment outcomes earlier using a simple scalp microscope, potentially reducing the need for repeated lab tests.
- What could go wrong
- This is a small observational study, not a controlled trial, so the findings may not apply to all patients or settings. The predictive value of trichoscopic signs may vary by fungus type.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TINEA CAPITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medeniyet University
Istanbul, Kadıköy, 34728, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.